The Board remands the case to obtain further medical input regarding the relationship between the veteran's prostate cancer and his service-connected retained metallic shrapnel in his prostate gland, specifically addressing whether the veteran's prostate cancer was aggravated by an inability to undergo radiation therapy or a delay in diagnosis due to the presence of the shrapnel.
The deciding factor: The Board finds that further medical input from the VA physician who evaluated the veteran is necessary as the examiner did not fully address the question of aggravation of the veteran's prostate cancer as a result of the presence of metallic shrapnel in the area of his prostate, and to obtain an addendum addressing whether the delay in diagnosis due to the inability to undergo MRI studies aggravated the condition.
- Claimed conditions
- adenocarcinoma of the prostate
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 27, 2008
- Citation
- 0810238
Veterans Law Judge
Decisions by this judge: 1,419 · Granted: 21% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0810238.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's adenocarcinoma of the prostate is rated at 60 percent effective February 5, 2021. An effective date of August 5, 2020 for a 20 percent rating for diabetes mellitus type II has been granted. The Veteran's bilateral hearing loss and verruca vulgaris of the right hand are not rated as compensable.
- Whole decision: Denied
The Veteran's cause of death, cardiorespiratory arrest and adult failure to thrive, is not service-connected as there is no evidence linking these conditions to his military service or exposure to herbicide agents. The Board finds that the medical evidence does not support a finding of service connection.
- Whole decision: Granted
The Veteran's prostate condition was restored to a 60% rating effective December 16, 2025.,An earlier effective date of August 23, 2012, for the grant of TDIU is granted.,SMC at the housebound rate is granted effective September 4, 2025.
- Whole decision: Granted
The Veteran's service-connected disabilities, including prostate cancer and urothelial cell carcinoma of the bladder, tinnitus, and urethritis, have prevented him from securing or following substantially gainful employment. The Board has granted a TDIU based on these conditions.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.